Zobrazeno 1 - 10
of 1 085
pro vyhledávání: '"Parkinson's Disease Dementia"'
Publikováno v:
Living with Mild Cognitive Impairment : A Guide to Maximizing Brain Health and Reducing the Risk of Dementia, 2024.
Externí odkaz:
https://doi.org/10.1093/oso/9780197749340.003.0006
Autor:
Chaeyoung Song, Jihye Oh, Young-Chan Kim, Yoo-Hyun Um, Tae-Won Kim, Ho-Jun Seo, Jong-Hyun Jeong, Seung-Chul Hong
Publikováno v:
Sleep Medicine Research, Vol 15, Iss 2, Pp 124-129 (2024)
Background and Objective The complex relationship between obstructive sleep apnea (OSA) and neurodegenerative diseases is increasingly being recognized. This study aims to elucidate the association between OSA and α-synucleinopathies, with a focus o
Externí odkaz:
https://doaj.org/article/c6b9fe0c689a4bce801b04db7292879d
Autor:
Michael Siu-Lun Lai, Maja Højvang Sørensen, Krit Lee, John Man-Tak Chu, Raymond Chuen-Chung Chang
Publikováno v:
Neurobiology of Disease, Vol 202, Iss , Pp 106723- (2024)
Parkinson's disease dementia (PDD) is commonly developed in patients at the late stage of Parkinson's disease (PD) with unknown progression mechanisms. From the post-mortem tissues and animal models, the ventral tegmental area (VTA) and the CA2 regio
Externí odkaz:
https://doaj.org/article/0c1308a963134880a568951c439dc729
Publikováno v:
Frontiers in Aging Neuroscience, Vol 16 (2024)
Cognitive impairments are a common feature of synucleinopathies such as Parkinson’s Disease Dementia and Dementia with Lewy Bodies. These pathologies are characterized by accumulation of Lewy bodies and Lewy neurites as well as neuronal cell death.
Externí odkaz:
https://doaj.org/article/33988c4562484f9abc568fba9f01871e
Publikováno v:
Frontiers in Neuroscience, Vol 18 (2024)
BackgroundDementia with Lewy bodies (DLB) can be difficult to distinguish from Alzheimer’s disease (AD) and Parkinson’s disease dementia (PDD) at different stages of its progression due to some overlaps in the clinical and neuropathological prese
Externí odkaz:
https://doaj.org/article/dc0b770d0c4c4f41a9adf842be695bbb
Publikováno v:
Acta Neuropathologica Communications, Vol 12, Iss 1, Pp 1-12 (2024)
Abstract Dementia with Lewy bodies (DLB), Parkinson’s disease dementia (PDD), and Parkinson’s disease (PD) collectively known as Lewy body diseases (LBDs) are neuropathologically characterised by α-synuclein deposits (Lewy bodies and Lewy neurit
Externí odkaz:
https://doaj.org/article/d09b77a1c1394f8b91fa58eeb977f7fe
Autor:
Zeynep Tufekcioglu, Johannes Lange, Kenn Freddy Pedersen, Ole-Bjørn Tysnes, Guido Alves, Murat Emre
Publikováno v:
Dementia and Geriatric Cognitive Disorders Extra, Vol 13, Iss 1, Pp 39-47 (2023)
Introduction: In patients with Parkinson’s disease (PD), low cerebrospinal fluid (CSF) amyloid beta 1-42 (Ab42) at baseline is the most consistent CSF biomarker as a risk factor for developing dementia. Low CSF Ab42 is, however, a typical hallmark
Externí odkaz:
https://doaj.org/article/8b06be49469348fc9882a199b4a7d9fb
Autor:
Afaf Albalawi
Publikováno v:
BMC Geriatrics, Vol 23, Iss 1, Pp 1-4 (2023)
Abstract Background Evidence is limited regarding the optimal therapeutic approach for neuropsychiatric symptoms associated with Parkinson’s disease dementia (PDD). Selective serotonin reuptake inhibitors (SSRIs) are widely used for mood disorders
Externí odkaz:
https://doaj.org/article/c437ae2f8f384f3db822ae40c4304b65
Autor:
Jennifer S. Pigott, Nathan Davies, Elizabeth Chesterman, Joy Read, Danielle Nimmons, Kate Walters, Megan Armstrong, Anette Schrag
Publikováno v:
Health Expectations, Vol 27, Iss 1, Pp n/a-n/a (2024)
Abstract Background Cognitive impairment is common in Parkinson's disease and is associated with poorer quality of life and increased caregiver distress, but little qualitative information is available on lived experiences of people with Parkinson's
Externí odkaz:
https://doaj.org/article/bdf0b2fce0374002b03bd86aa4a18e49
Autor:
Huimin Yan, Minglei Liu, Yuan Gao, Yanpeng Yuan, Xiaojing Liu, Yangyang Wang, Lanjun Li, Qingzhi Wang, Yanlin Wang, Changhe Shi, Yuming Xu, Jing Yang
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
BackgroundOverwhelming evidence points to that genetic factors contributing to the development of Alzheimer’s disease (AD) and Parkinson’s disease (PD). Genome-Wide Association Study (GWAS) has come a long way in the last decade. So far, a large
Externí odkaz:
https://doaj.org/article/84b18ba911bc4690959065a4b632282f